(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 7. Integrins compensate for the absence of PrPC to support Vn-induced axonal growth. (a) VnRGD peptide abrogates Vn-induced axonal growth in cultured ZrchI Prnp0/0 (grey bars) DRGs at lower concentrations (8 µM) than that (12 µM) necessary for the same effect in Prnp+/+ (white bars) DRGs. Treatment with the irrelevant peptide Vn161-174 (12 µM) had no effect. *P<0.001 vs poly-L-lysine (Pll) Tukey's test. (b) Exposure to adsorbed VnRGD-BSA peptide (0.5, 5, 1 or 10 nmol) increased axonal growth in DRG cells from ZrchI Prnp0/0 mice, but not from ZrchI Prnp+/+ mice. *P<0.001 vs Pll control, Tukey's test. (c) Adsorbed VnRGD-BSA peptide (1 nmol) induced axonal growth in cultured DRG cells from Npu Prnp/ mice (black bars) whereas no axonal growth was present at this concentration of absorbed VnRGD-BSA peptide in Npu Prnp+/+ cells (striped bars). *P<0.001 vs Pll control, Tukey's test. (d) ZrchI Prnp0/0 dissociated DRG cells exhibited greater WOW-1 immunoreactivity than those from ZrchI Prnp+/+ mice, indicating that the knockouts had greater levels of activated
v
3 integrin. *P<0.001 vs Prnp+/+, Mann-Whitney's test. (e) Npu Prnp/ dissociated DRG cells exhibited greater AP5 immunoreactivity than Npu Prnp+/+, indicating that the knockouts had greater levels of activated
3 integrin. *P<0.001 vs Npu Prnp+/+, Mann-Whitney's test.